These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3757392)

  • 1. Pharmacokinetics of intravenously administered 125I-labelled human alpha 1-acid glycoprotein.
    Brée F; Houin G; Barré J; Moretti JL; Wirquin V; Tillement JP
    Clin Pharmacokinet; 1986; 11(4):336-42. PubMed ID: 3757392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
    Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
    Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and toxicity of high-dose human alpha 1-acid glycoprotein infusion in the rat.
    Keyler DE; Pentel PR; Haughey DB
    J Pharm Sci; 1987 Feb; 76(2):101-4. PubMed ID: 3572744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis].
    Wiesner G; Taeger K; Peter K
    Anaesthesist; 1996 Apr; 45(4):323-9. PubMed ID: 8702049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human alpha-1-glycoprotein and its interactions with drugs.
    Israili ZH; Dayton PG
    Drug Metab Rev; 2001 May; 33(2):161-235. PubMed ID: 11495502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.
    Smith SA; Waters NJ
    Pharm Res; 2018 Dec; 36(2):30. PubMed ID: 30593605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients.
    Haughey DB; Kraft CJ; Matzke GR; Keane WF; Halstenson CE
    Am J Nephrol; 1985; 5(1):35-9. PubMed ID: 3881959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependency of basic ligand binding to alpha 1-acid glycoprotein (orosomucoid).
    Urien S; Brée F; Testa B; Tillement JP
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):277-80. PubMed ID: 1741754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Drug Binding to Human Serum Albumin and Alpha One Acid Glycoprotein in Diseased and Age Patient Populations.
    McNamara PJ; Meiman D
    J Pharm Sci; 2019 Aug; 108(8):2737-2747. PubMed ID: 30905706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
    Huang Z; Ung T
    Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-induced changes in the plasma binding of basic drugs.
    Piafsky KM
    Clin Pharmacokinet; 1980; 5(3):246-62. PubMed ID: 6156048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased elimination of unbound prazosin in the presence of alpha 1-acid glycoprotein in the rat in vivo.
    Oie S; Fiori F; Chiang J
    J Pharmacol Exp Ther; 1987 Jun; 241(3):934-8. PubMed ID: 3598910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of altered plasma alpha-1-acid glycoprotein levels on pharmacokinetics of some basic antibiotics in pigs: simulation analysis.
    Kuroha M; Son DS; Shimoda M
    J Vet Pharmacol Ther; 2001 Dec; 24(6):423-31. PubMed ID: 11903873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects.
    Kishino S; Nomura A; Di ZS; Sugawara M; Iseki K; Kakinoki S; Kitabatake A; Miyazaki K
    J Clin Pharmacol; 1995 May; 35(5):510-4. PubMed ID: 7657852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein binding predictions in infants.
    McNamara PJ; Alcorn J
    AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interethnic differences in drug protein binding and alpha 1 acid glycoprotein concentration.
    Hosseine SJ; Farid R; Ghalighi MR; Feely J
    Ir J Med Sci; 1995 Jan; 164(1):26-7. PubMed ID: 7890529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.
    Piafsky KM; Borgå O
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):545-9. PubMed ID: 913021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.